Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.zenotechlab.com | |
Market Cap | 405.49 Cr. | |
Enterprise Value(EV) | 405.49 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 1.53 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 43.47 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.75 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 14.19 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 4.68 | Calculated using Price: 66.44 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 6.10 Cr. | 61,030,568 Shares |
FaceValue | 10 | |
About Zenotech Laboratories Ltd. | ||
Zenotech Laboratories Ltd, formerly known as Sunline Technologies Limited, was originally incorporated as Maa Shakti Tube Mill private Limited on June 15,1989. Zenotech develops and manufactures generic biopharmaceuticals and markets them to people with unmet medical needs around the world. |
1 Day |
|
+0.98% |
1 Week |
|
-0.12% |
1 Month |
|
-1.65% |
3 Month |
|
+26.28% |
6 Month |
|
+28.34% |
1 Year |
|
|
2 Year |
|
+53.16% |
5 Year |
|
+72.57% |
10 Year |
|
+163.53% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -7.73 | 24.35 | -2.48 | 37.26 | 15.15 | |||||
Return on Capital Employed (%) | -61.52 | -65.68 | -61.88 | -5.95 | 18.32 | 0.48 | 15.26 | 18.39 | ||
Return on Assets (%) | -45.43 | -32.82 | -38.33 | -17.89 | -3.76 | 12.67 | -1.42 | 26.45 | 13.37 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | -27 | -46 | -66 | 42 | 39 | 50 | 48 | 71 | 82 | 87 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 22 | -4 | -7 | -6 | |
Curr. Liab. | 91 | 99 | 116 | 39 | 45 | 35 | 15 | 16 | 17 | 15 | |
Minority Int. | |||||||||||
Equity & Liab. | 64 | 53 | 51 | 82 | 85 | 86 | 86 | 82 | 92 | 96 | |
Non Curr. Assets | 55 | 50 | 49 | 50 | 65 | 80 | 79 | 74 | 75 | 74 | |
Curr. Assets | 8 | 3 | 2 | 31 | 19 | 6 | 7 | 7 | 16 | 22 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 64 | 53 | 51 | 82 | 85 | 86 | 86 | 82 | 92 | 96 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 4 | 2 | 2 | 11 | 13 | 26 | 22 | 37 | 42 | 41 | |
Other Income | 0 | 0 | 0 | 2 | 5 | 1 | 0 | 1 | 1 | 1 | |
Total Income | 4 | 2 | 2 | 14 | 18 | 27 | 23 | 37 | 44 | 41 | |
Total Expenditure | -24 | -10 | -13 | -19 | -17 | -17 | -16 | -19 | -22 | -23 | |
PBIDT | -20 | -8 | -10 | -6 | 1 | 10 | 7 | 18 | 22 | 19 | |
Interest | -7 | -8 | -8 | -2 | 0 | -1 | -2 | -1 | 0 | ||
Depreciation | -4 | -4 | -4 | -4 | -4 | -5 | -6 | -7 | -7 | -7 | |
Taxation | 12 | -3 | -2 | ||||||||
Exceptional Items | 2 | 6 | |||||||||
PAT | -30 | -19 | -20 | -12 | -3 | 11 | -1 | 22 | 12 | 9 | |
Adjusted EPS | -8 | -5 | -5 | -2 | -1 | 2 | 0 | 4 | 2 | 2 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | -24 | -8 | -5 | 2 | -16 | -14 | 11 | 6 | 18 | 21 | |
Cash Fr. Inv. | -1 | 0 | 6 | -1 | -3 | -16 | -21 | -5 | -2 | -6 | |
Cash Fr. Finan. | 30 | 7 | -1 | -1 | 47 | 15 | -3 | 0 | -16 | -6 | |
Net Change | 5 | -1 | 0 | 0 | 28 | -15 | -12 | 1 | 0 | 9 | |
Cash & Cash Eqvt | 6 | 6 | 0 | 0 | 28 | 13 | 1 | 2 | 2 | 11 |
Wed, 01 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Extract of Unaudited Financial Results for the quarter and half year ended September 30 2023 |
Mon, 30 Oct 2023
Outcome Of The Board Meeting For Consideration And Approval Of Financial Results For The Quarter And Half Year Ended September 30 2023 Unaduited Financial Results of the Company for the quarter and half year ended September 30 |
Mon, 30 Oct 2023
Unaudited Financial Results For The Quarter And Half Year Ended September 30 2023 Unaudited Financial Results for the quarter and half year ended September 30 2023 |
Fri, 01 Dec 2023 |
|
|
|
|
|